Charles River Laboratories Intl. Inc vs Samsara Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $282 (market cap $13.46B), while Samsara Inc trades at $40.08 (market cap $23.49B). The key difference: Samsara Inc is the larger of the two by market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Samsara Inc nearer its low. Which is the better fit depends on your goals.
| CRL | IOT | |
|---|---|---|
Market Cap | $13.46B | $23.49B |
Sector | Health | Technology |
52-Week High | $282.00 | $45.22 |
52-Week Low | $145.57 | $24.25 |
Enterprise Value | $16.30B | $22.76B |
Trailing returns across standard periods
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →Samsara provides a connected operations cloud that uses IoT data to help businesses improve efficiency and safety. Its platform offers real-time visibility for fleet management, equipment monitoring, and industrial sites.
Read more on IOT →